Report Detail

Pharma & Healthcare Global Pleuromutilin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4569324
  • |
  • 08 December, 2023
  • |
  • Global
  • |
  • 106 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pleuromutilin market size was valued at USD 100.2 million in 2022 and is forecast to a readjusted size of USD 138.6 million by 2029 with a CAGR of 4.7% during review period.
Pleuromutilin is a broad-spectrum diterpene antibiotic produced by Pleurotus mutilus. It is the precursor of semi-synthetic derivatives of pleuromutilin and can effectively inhibit most Gram-negative bacteria. positive bacteria and some Gram-negative bacteria.
Pleuromutilin is a class of antibacterial substances that work by inhibiting the synthesis of protein in bacteria. Pleuromutilins were discovered in the 1950s mainly for veterinary purposes. Pleuromutilin is used for the treatment and prevention of gastrointestinal and respiratory infections caused by different bacterial pathogens in pigs, poultry and rabbits.
In our report, our statistical standard is based on 100% content. Active Ingredient Contents is 100%.
Global key players of Pleuromutilin include Sunny Biotech, Hebei Weiyuan, Shandong Shengli, Shandong Lukang, etc. Global top four manufacturers hold a share over 55%.
Asia-Pacific is the largest market of Pleuromutilin, holds a share over 90%, followed by Asia-Pacific, North America.
In terms of application, the largest application is Livestock, with a share around 90%, followed by Poultry.
The Global Info Research report includes an overview of the development of the Pleuromutilin industry chain, the market status of Livestock (Premix, API Powder), Poultry (Premix, API Powder), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pleuromutilin.
Regionally, the report analyzes the Pleuromutilin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pleuromutilin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pleuromutilin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pleuromutilin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Premix, API Powder).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pleuromutilin market.
Regional Analysis: The report involves examining the Pleuromutilin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pleuromutilin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pleuromutilin:
Company Analysis: Report covers individual Pleuromutilin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pleuromutilin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Livestock, Poultry).
Technology Analysis: Report covers specific technologies relevant to Pleuromutilin. It assesses the current state, advancements, and potential future developments in Pleuromutilin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pleuromutilin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pleuromutilin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Premix
API Powder
Market segment by Application
Livestock
Poultry
Major players covered
Sunny Biotech
Hebei Weiyuan
Shandong Shengli
Shandong Lukang
Qingdao Dierman
Qilu Pharma
Huvepharma
Novartis
Vethellas
Elanco
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pleuromutilin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pleuromutilin, with price, sales, revenue and global market share of Pleuromutilin from 2018 to 2023.
Chapter 3, the Pleuromutilin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pleuromutilin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pleuromutilin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pleuromutilin.
Chapter 14 and 15, to describe Pleuromutilin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Pleuromutilin
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pleuromutilin Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Premix
    • 1.3.3 API Powder
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pleuromutilin Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Livestock
    • 1.4.3 Poultry
  • 1.5 Global Pleuromutilin Market Size & Forecast
    • 1.5.1 Global Pleuromutilin Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Pleuromutilin Sales Quantity (2018-2029)
    • 1.5.3 Global Pleuromutilin Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sunny Biotech
    • 2.1.1 Sunny Biotech Details
    • 2.1.2 Sunny Biotech Major Business
    • 2.1.3 Sunny Biotech Pleuromutilin Product and Services
    • 2.1.4 Sunny Biotech Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sunny Biotech Recent Developments/Updates
  • 2.2 Hebei Weiyuan
    • 2.2.1 Hebei Weiyuan Details
    • 2.2.2 Hebei Weiyuan Major Business
    • 2.2.3 Hebei Weiyuan Pleuromutilin Product and Services
    • 2.2.4 Hebei Weiyuan Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Hebei Weiyuan Recent Developments/Updates
  • 2.3 Shandong Shengli
    • 2.3.1 Shandong Shengli Details
    • 2.3.2 Shandong Shengli Major Business
    • 2.3.3 Shandong Shengli Pleuromutilin Product and Services
    • 2.3.4 Shandong Shengli Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Shandong Shengli Recent Developments/Updates
  • 2.4 Shandong Lukang
    • 2.4.1 Shandong Lukang Details
    • 2.4.2 Shandong Lukang Major Business
    • 2.4.3 Shandong Lukang Pleuromutilin Product and Services
    • 2.4.4 Shandong Lukang Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Shandong Lukang Recent Developments/Updates
  • 2.5 Qingdao Dierman
    • 2.5.1 Qingdao Dierman Details
    • 2.5.2 Qingdao Dierman Major Business
    • 2.5.3 Qingdao Dierman Pleuromutilin Product and Services
    • 2.5.4 Qingdao Dierman Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Qingdao Dierman Recent Developments/Updates
  • 2.6 Qilu Pharma
    • 2.6.1 Qilu Pharma Details
    • 2.6.2 Qilu Pharma Major Business
    • 2.6.3 Qilu Pharma Pleuromutilin Product and Services
    • 2.6.4 Qilu Pharma Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Qilu Pharma Recent Developments/Updates
  • 2.7 Huvepharma
    • 2.7.1 Huvepharma Details
    • 2.7.2 Huvepharma Major Business
    • 2.7.3 Huvepharma Pleuromutilin Product and Services
    • 2.7.4 Huvepharma Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Huvepharma Recent Developments/Updates
  • 2.8 Novartis
    • 2.8.1 Novartis Details
    • 2.8.2 Novartis Major Business
    • 2.8.3 Novartis Pleuromutilin Product and Services
    • 2.8.4 Novartis Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Novartis Recent Developments/Updates
  • 2.9 Vethellas
    • 2.9.1 Vethellas Details
    • 2.9.2 Vethellas Major Business
    • 2.9.3 Vethellas Pleuromutilin Product and Services
    • 2.9.4 Vethellas Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Vethellas Recent Developments/Updates
  • 2.10 Elanco
    • 2.10.1 Elanco Details
    • 2.10.2 Elanco Major Business
    • 2.10.3 Elanco Pleuromutilin Product and Services
    • 2.10.4 Elanco Pleuromutilin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Elanco Recent Developments/Updates

3 Competitive Environment: Pleuromutilin by Manufacturer

  • 3.1 Global Pleuromutilin Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Pleuromutilin Revenue by Manufacturer (2018-2023)
  • 3.3 Global Pleuromutilin Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Pleuromutilin by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Pleuromutilin Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Pleuromutilin Manufacturer Market Share in 2022
  • 3.5 Pleuromutilin Market: Overall Company Footprint Analysis
    • 3.5.1 Pleuromutilin Market: Region Footprint
    • 3.5.2 Pleuromutilin Market: Company Product Type Footprint
    • 3.5.3 Pleuromutilin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pleuromutilin Market Size by Region
    • 4.1.1 Global Pleuromutilin Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Pleuromutilin Consumption Value by Region (2018-2029)
    • 4.1.3 Global Pleuromutilin Average Price by Region (2018-2029)
  • 4.2 North America Pleuromutilin Consumption Value (2018-2029)
  • 4.3 Europe Pleuromutilin Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Pleuromutilin Consumption Value (2018-2029)
  • 4.5 South America Pleuromutilin Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Pleuromutilin Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Pleuromutilin Sales Quantity by Type (2018-2029)
  • 5.2 Global Pleuromutilin Consumption Value by Type (2018-2029)
  • 5.3 Global Pleuromutilin Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Pleuromutilin Sales Quantity by Application (2018-2029)
  • 6.2 Global Pleuromutilin Consumption Value by Application (2018-2029)
  • 6.3 Global Pleuromutilin Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Pleuromutilin Sales Quantity by Type (2018-2029)
  • 7.2 North America Pleuromutilin Sales Quantity by Application (2018-2029)
  • 7.3 North America Pleuromutilin Market Size by Country
    • 7.3.1 North America Pleuromutilin Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Pleuromutilin Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Pleuromutilin Sales Quantity by Type (2018-2029)
  • 8.2 Europe Pleuromutilin Sales Quantity by Application (2018-2029)
  • 8.3 Europe Pleuromutilin Market Size by Country
    • 8.3.1 Europe Pleuromutilin Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Pleuromutilin Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pleuromutilin Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Pleuromutilin Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Pleuromutilin Market Size by Region
    • 9.3.1 Asia-Pacific Pleuromutilin Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Pleuromutilin Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Pleuromutilin Sales Quantity by Type (2018-2029)
  • 10.2 South America Pleuromutilin Sales Quantity by Application (2018-2029)
  • 10.3 South America Pleuromutilin Market Size by Country
    • 10.3.1 South America Pleuromutilin Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Pleuromutilin Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pleuromutilin Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Pleuromutilin Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Pleuromutilin Market Size by Country
    • 11.3.1 Middle East & Africa Pleuromutilin Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Pleuromutilin Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Pleuromutilin Market Drivers
  • 12.2 Pleuromutilin Market Restraints
  • 12.3 Pleuromutilin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pleuromutilin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pleuromutilin
  • 13.3 Pleuromutilin Production Process
  • 13.4 Pleuromutilin Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pleuromutilin Typical Distributors
  • 14.3 Pleuromutilin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pleuromutilin. Industry analysis & Market Report on Pleuromutilin is a syndicated market report, published as Global Pleuromutilin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pleuromutilin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,745.72
    4,118.58
    5,491.44
    3,201.60
    4,802.40
    6,403.20
    539,991.60
    809,987.40
    1,079,983.20
    290,580.00
    435,870.00
    581,160.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report